Abstract

Diabetes during pregnancy increases the risk for adverse maternal and infant health outcomes. Type 1 or type 2 diabetes diagnosed before pregnancy (preexisting diabetes) increases infants' risk for congenital anomalies, stillbirth, and being large for gestational age (1). Diabetes that develops and is diagnosed during the second half of pregnancy (gestational diabetes) increases infants' risk for being large for gestational age (1) and might increase the risk for childhood obesity (2); for mothers, gestational diabetes increases the risk for future type 2 diabetes (3). In the United States, prevalence of both preexisting and gestational diabetes increased from 2000 to 2010 (4,5). Recent state-specific trends have not been reported; therefore, CDC analyzed 2012-2016 National Vital Statistics System (NVSS) birth data. In 2016, the crude national prevalence of preexisting diabetes among women with live births was 0.9%, and prevalence of gestational diabetes was 6.0%. Among 40 jurisdictions with continuously available data from 2012 through 2016, the age- and race/ethnicity-standardized prevalence of preexisting diabetes was stable at 0.8% and increased slightly from 5.2% to 5.6% for gestational diabetes. Preconception care and lifestyle interventions before, during, and after pregnancy might provide opportunities to control, prevent, or mitigate health risks associated with diabetes during pregnancy.

Highlights

  • What is already known about this topic

  • pregnancy increases the risk for adverse infant

  • What is added by this report

Read more

Summary

Centers for Disease Control and Prevention

MD, MPH, Deputy Director for Public Health Scientific Services William R. Mac Kenzie, MD, Acting Director, Center for Surveillance, Epidemiology, and Laboratory Services. Mary Dott, MD, MPH, Online Editor Teresa F. Weatherwax, Lead Technical Writer-Editor Glenn Damon, Soumya Dunworth, PhD, Teresa M. Jurisdictionspecific prevalences were calculated for each year after directly standardizing to the distribution of age and race/ethnicity of U.S resident mothers with live births in 2012 because these characteristics vary by jurisdiction and are nonmodifiable determinants of diabetes. By race/ethnicity, the prevalence of preexisting diabetes was highest among American Indian/Alaska Native women (2.1%) and Native Hawaiian/Pacific Islander women (1.8%), and the prevalence of gestational diabetes was highest among non-Hispanic Asian women (11.1%). Significant increases in the prevalence of preexisting diabetes were observed in eight jurisdictions (range = 0.1% [California] to 0.3% [Georgia]); a Among women with complete information on diabetic status, missing data ranged from

Obesity Class III
Percentage of women with gestational diabetes
DC NYC
Discussion
What is added by this report?
What are the implications for public health practice?
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call